Skip to main content
. 2017 Jan 19;8(9):14655–14665. doi: 10.18632/oncotarget.14738

Figure 6. MiR-29b inhibits cervical cancer growth in vivo.

Figure 6

(A) Graphic representing tumor volumes at the end of the experiment for mice treated with miR-29b mimic or scramble mimic. Five mice per group; (B) Tumor volume averages between scramble and miR-29b mimic treated mice groups at the indicated days during the experiment; (C) Tumor weight averages between scramble and miR-29b mimic treated mice groups at the end of the experiment (28 days); (D) Quantitative RT-PCR analysis showed the relative expression of miR-29b in injected tumor tissues (normalized to U6); (E) Representative images of the immunohistochemistry analysis of p-STAT3 and VEGF in tumors from xenograft mice. Data are presented as means ± SD. **P < 0.01.